Sponsor or institution

Clinical trials and research at Pharmicell Co., Ltd.

As of November 12, 2026, Find a Trial lists 4 clinical trials run by Pharmicell Co., Ltd. that are recruiting, in South Korea. By phase: Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

Newest trials

StudyPhaseWhereStatusRegistered
Long-term safety follow-up of Cellgram-ED for erectile dysfunction after prostate removal — Seoul and 3 other locations Recruiting Feb 24, 2026
Long-term follow-up after Hearticellgram-AMI treatment — Seoul, Gangnam Recruiting Feb 10, 2026
Long-term follow-up for patients with alcoholic liver cirrhosis treated with Cellgram-LC — Ansan and 13 other locations Recruiting Oct 26, 2021
Evaluating Cellgram-LC for Alcoholic Cirrhosis Treatment Phase 3 Ansan and 14 other locations Recruiting Dec 30, 2020

All recruiting trials (4)

Quick answers

How many clinical trials run by Pharmicell Co., Ltd. are recruiting right now?

4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in South Korea. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.